Cargando…

Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer’s disease

INTRODUCTION: Alzheimer’s disease (AD) is a progressive and debilitating neurodegenerative disorder prevalent among older adults. Although AD symptoms can be managed through certain treatments, advancing the understanding of underlying disease mechanisms and developing effective therapies is critica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Wenhao, Su, Yuelin, Zhang, Peng, Wan, Guoqing, Cheng, Xiaoqin, Lu, Changlian, Gu, Xuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352499/ https://www.ncbi.nlm.nih.gov/pubmed/37470054 http://dx.doi.org/10.3389/fnmol.2023.1205541

Ejemplares similares

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022)

Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas
por: Liu, Yi, et al.
Publicado: (2022)

Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
por: Sbai, Oualid, et al.
Publicado: (2023)

Identification of diagnostic biomarkers in Alzheimer’s disease by integrated bioinformatic analysis and machine learning strategies
por: Jin, Boru, et al.
Publicado: (2023)

Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021)

Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023)

Identification ferroptosis-related hub genes and diagnostic model in Alzheimer’s disease
por: Zhao, Huabin, et al.
Publicado: (2023)

Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer’s disease
por: Ma, Zhaotian, et al.
Publicado: (2022)

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)

Identification of Alzheimer’s Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing
por: Ma, Meigang, et al.
Publicado: (2022)

Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
por: Fu, Xuanhao, et al.
Publicado: (2023)

Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
por: Fu, Xuanhao, et al.
Publicado: (2023)

Cofilin 2 Acts as an Inflammatory Linker Between Chronic Periodontitis and Alzheimer’s Disease in Amyloid Precursor Protein/Presenilin 1 Mice
por: Zeng, Qing, et al.
Publicado: (2021)

Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
por: Zhou, Kai, et al.
Publicado: (2022)

Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation
por: Mesa-Herrera, Fátima, et al.
Publicado: (2022)

Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers
por: Zhang, Meng, et al.
Publicado: (2021)

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis
por: Yu, Wuhan, et al.
Publicado: (2021)

High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers
por: Ma, Jingjing, et al.
Publicado: (2023)

Mouse Models of Alzheimer’s Disease
por: Yokoyama, Miyabishara, et al.
Publicado: (2022)

Interrelation between homocysteine metabolism and the development of autism spectrum disorder in children
por: Li, Bingbing, et al.
Publicado: (2022)

Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod
por: Jęśko, Henryk, et al.
Publicado: (2021)

Synapse integrity and function: Dependence on protein synthesis and identification of potential failure points
por: Cohen, Laurie D., et al.
Publicado: (2022)

Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics
por: Dalmasso, María C., et al.
Publicado: (2023)

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
por: Morrison, D H, et al.
Publicado: (2012)

The complete chloroplast genome of Strobilanthes crispus (Acanthaceae)
por: Wan, Guoqing, et al.
Publicado: (2022)

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer’s disease
por: Fan, Li-Yuan, et al.
Publicado: (2023)

Deleterious Variation in BR Serine/Threonine Kinase 2 Classified a Subtype of Autism
por: Deng, Jingxin, et al.
Publicado: (2022)

Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
por: Shao, Tiannan, et al.
Publicado: (2022)

GAP-43 closely interacts with BDNF in hippocampal neurons and is associated with Alzheimer's disease progression
por: Lee, Ye Ji, et al.
Publicado: (2023)

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020)

Identification and prediction of m7G-related Alzheimer’s disease subtypes: insights from immune infiltration and machine learning models
por: Ma, Chao, et al.
Publicado: (2023)

Perivascular spaces as a potential biomarker of Alzheimer’s disease
por: Lynch, Miranda, et al.
Publicado: (2022)

Mechanism of PGC-1α-mediated mitochondrial biogenesis in cerebral ischemia–reperfusion injury
por: Yuan, Ying, et al.
Publicado: (2023)

Targeting the metabolic profile of amino acids to identify the key metabolic characteristics in cerebral palsy
por: Wang, Dan, et al.
Publicado: (2023)

Mitochondrial Extracellular Vesicles – Origins and Roles
por: Amari, Lydia, et al.
Publicado: (2021)

Editorial: Mitochondrial therapy in neurological diseases
por: Chang, Jui-Chih, et al.
Publicado: (2022)

Identification and Analysis of Potential Autophagy-Related Biomarkers in Endometriosis by WGCNA
por: Wang, Jing, et al.
Publicado: (2021)

Circulating MicroRNAs From Plasma Small Extracellular Vesicles as Potential Diagnostic Biomarkers in Pediatric Epilepsy and Drug-Resistant Epilepsy
por: Wang, Yilong, et al.
Publicado: (2022)

Potential novel therapeutic strategies for neuropathic pain
por: Du, Zelu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_esspm28rdijh0d4q44ne16odgk